In such turbulent times, pharmacovigilance has been also affected by the unexpected changes of the World. BREXIT and Trump tornado, what else to come? In order to stay up-to-date our 5th Annual Pharmacovigilance Forum is a perfect opportunity to hear the most important updates of the industry. We bring together the top minds of the pharmaceutical industry from all over Europe to share their experiences and best practices and to network with their peers. Topics such as BREXIT vs. Pharmacovigilance, effectiveness evaluation of risk minimization measures, signal detection and Eudravigilance, GVP guidance, significance of outsourcing and many more will be discussed and consulted during our event. For those interested in Biosimilars Dr. Niraj Chhaya from Boehringer Ingelheim GmbH will present the success factor of biosimilars.
We are also happy to welcome Andrew A. Parsons on board from Reciprocal Minds Limited who will talk about human factors in Pharma R&D. This is a special feature to the event which will be a great added value to the audience. Stay up-to-date and join our upcoming event to meet these leaders of the industry and listen their inspiring presentations in order to take home the most beneficial outcome for you and your company.
Senior Pharmacovigilance Regulators and Inspectors, Pharmacovigilance and Drug Safety Officers, Regulatory Affairs Officers, Clinical Risk-Benefit Groups, Local Medicines Authorities, CRO and Consultants providing QPPV Services, Pharma Industry Heads, Directors and Managers OF: